Steven Paris
Primary Care · Austin, TXNPI 1629622071
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,942 of the $10,484 with a category attached, or 75.8%. 27 manufacturers reported payments, led by Merck at 25.9% of the total. 2025 is the largest year on record at $5,938, more than ten times the $426 reported in 2021. Among primary care clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 338 payments — averaging $31.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$3K
- Gilead$3K
- Viiv Healthcare Company$3K
- Theratechnologies Inc.$629
- Novo Nordisk$440
- AstraZeneca$211
- plus $1K from 21 others
What the payments were for
- Consulting fees$5005%
- Travel & lodging$2,04119%
- Food & beverage$7,94276%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 29 | $2,712 |
| Gilead | 118 | $2,639 |
| Viiv Healthcare Company | 89 | $2,570 |
| Theratechnologies Inc. | 6 | $629 |
| Novo Nordisk | 22 | $440 |
| AstraZeneca | 13 | $211 |
| Lilly USA, LLC | 13 | $199 |
| AbbVie | 5 | $106 |
| Harmony Biosciences LLC | 1 | $106 |
| Pfizer | 6 | $105 |
| EMD Serono, Inc. | 3 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $94 |
| GSK | 5 | $94 |
| Organon | 1 | $81 |
| Amgen | 4 | $67 |
| Hologic Sales And Service, LLC | 2 | $55 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Halozyme Inc | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Exact Sciences | 2 | $29 |
| Dexcom, Inc. | 1 | $24 |
| TMS Neurohealth Centers Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $22 |
| Tolmar, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Antares Pharma, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,484 in reported general payments places this provider in the 95th percentile of 563 primary care providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 25 | $29,128 |
| OzempicSemaglutide | 19 | $20,703 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $281 |
| Estradiol | 12 | $202 |
| Amlodipine Besylate | 15 | $36 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $199 | $29,12825 claims |
| Novo NordiskOzempic | $440 | $20,70319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 563 primary care providers in Texas.
Other primary care in Austin
- Mary GibbensHouston$42K
- Phillip GulleySan Antonio$23K
- Herbert BautistaDallas$14K
- Brandi JoynerLongview$12K
- Hope OdomCollege Station$10K
- Arlena GraysTomball$9K
- Charlotte BallardSan Antonio$9K
- Hannah LancasterMcKinney$9K
- Jacqueline MilesGrand Prairie$9K
- Christopher LoganSan Antonio$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.